I am an independent equity research analyst and consultant. I focus on finding small-cap biotech stocks where I believe there is favorable risk / reward because of misinformation, lack of information, or a potential fundamental turnaround. I provide detail analysis for investors and investor relations companies. I also provide due diligence and advisory services to companies. Some names I write on I invest in personally and will disclose my position. Names that have hired me to provide due diligence or advisory services I will disclose a business relationship.
I previously worked for Zacks Investment Research from 2003 to 2015 as a Senior Biotechnology Analyst. Prior to Zacks, I spent 1999 to 2002 managing money with Eastover Capital in Charlotte, NC where I focused on large-cap equities, specializing in healthcare, energy, and technology. Prior to joining Eastover, I worked as a research scientist for TechLab, Inc., a biotechnology company focused on developing diagnostic kits and vaccines for infectious diseases, between 1995 and 1998. I also spent a year working at the Fralin Biotechnology Center, and a year working for a cancer researcher while at Virginia Tech.
I have a B.S. in Biochemistry from Virginia Tech, with a B.A in Chemistry and a minor in Math. I have a M.B.A. in Finance, with a concentration in Securities Analysis, from Wake Forest University. I hold the Chartered Financial Analyst (CFA) designation.
I joined Seeking Alpha in February 2014 as editor of the biotech vertical. In addition to onboarding new contributors, my job is to make sure Seeking Alpha provides high-quality and comprehensive coverage of the biotechnology and health care sectors. I am always looking for new ideas, so please reach out if you're interested.
Team of hardcore quantitative researchers (i.e quants) that comb through academic research and perform historical backtests to generate unique insights into US equities for investors and firms that don't have access to their own in-house quant team. We've packaged our ideas and algorithms into an easy to use, web application software called QuantifiedAlpha.com. This software provides data and predictive analytics on over 3,000 US equities. It bridges the gap between financial academia and mainstream investing, at an affordable price.
Search up a stock on www.QuantifiedAlpha.com, and see what the quant algorithms indicate about its future direction.
I am a Master of Financial Engineering student at UC Berkeley with a bachelor in Engineering Science, Applied Physics taking a quantitative approach to investing and trading.
I was the portfolio director at Capital Investments at Berkeley, a student run hedge-fund. My strategies are centered around risk management, market hedging and the financial instruments that I primarily use are equities, fixed income assets and options.
Find me on LNKD: http://www.linkedin.com/pub/john-gay/41/201/653
Marina Avilkina is the person behind 'Timing Best Buy'. She is an Associate Professor and hold Ph.D. degree in Economics. She is the author of three books on finance published in. She is also business writer, academic researcher and investor.
"My forte is Finance. I am particularly focused on investigating stock trends. I utilize my financial and economic experience, as well as thorough research, to gauge the progress and outlook of individual stocks. My goal is to provide relevant information and prudent advice to investors, helping them make informed and sensible investment decisions."
Ashraf Eassa is a technology specialist with The Motley Fool. He writes mostly about technology stocks, but is especially interested in anything related to chips -- the semiconductor kind, that is.
Stephen Aniston is a financial technology software manager, architect and developer with over 10 years of experience in the financial industry. He was Technical Architect for the Merchant Bank at Goldman Sachs and Technology Vice President for the Investment Bank at the Royal Bank of Scotland. Prior to that he had stints at hedge fund investment firms (commonly called fund-of-funds) K2 Advisors and Ivy Asset Management. He graduated from Stanford University with an engineering degree in the late 90s.
Currently, he is President of Money Loop, a financial research firm that focuses on volatility. The company operates VIXCONTANGO.COM, the best source for volatility data, analytics, trade alerts, dashboards and reports on the internet. VIXCONTANGO provides real-time data and daily analysis of the VIX Futures Curve (VX), the CBOE spot VIX indices (VXST, VIX, VXV, VXMT) and the S&P 500 index (SPX). Our proprietary indicators, the VIX Contango Oscillator (VCO) and the VIX Term Roll Oscillator (VTRO), aggregate volatility expectations across time and help investors identify opportunities to exploit futures contango rollover in Volatility ETFs for trading profits. By monitoring changes in volatility expectations, investors can also spot important turning points in the markets and time them successfully.
Brad Thomas is a research analyst and he currently writes weekly for Forbes and Seeking Alpha where he maintains research on many publicly-listed REITs. In addition, Thomas is the Senior Analyst at iREIT Forbes and Editor of the Forbes Real Estate Investor, a monthly subscription-based newsletter.
Thomas has also been featured in Forbes Magazine, Kiplinger’s, US News & World Report, Money, NPR, Institutional Investor, GlobeStreet, and Fox Business. He was the #1 contributing analyst on Seeking Alpha in 2014 (as ranked by TipRanks) and he is currently writing a book on the legendary investor Donald Trump. In addition, Thomas is co-authoring a book (The Intelligent REIT Investor) that will e published in August 2016.
Thomas received a Bachelor of Science degree in Business/Economics from Presbyterian College where he played basketball. He resides in South Carolina with his wife and kids.
Alan Brochstein, CFA, was the first investment professional to devote himself to sharing his observations about the cannabis industry from an investor's perspective publicly. He runs 420 Investor, a subscription-based due diligence platform for investors interested in the publicly-traded cannabis stocks and is also the founder of New Cannabis Ventures, a content aggregation site focused on investors and entrepreneurs in the cannabis industry.
Alan has worked in the securities industry since 1986, primarily with the responsibility for managing investments in institutional environments until he founded AB Analytical Services in 2007 in order to provide independent research and consulting to registered investment advisors. In addition to advising several different hedge funds and investment managers, including Friedberg Investment Management, where he participated as a member of its investment management committee, Alan was also a senior analyst for the independent research firm Management CV. In 2008, he began providing a first-of-its-kind subscription-based service for individual investors, Invest By Model, which offered two different portfolios that investors could replicate in their own accounts for $20 per month. Alan also offered The Analytical Trader at Marketfy, where he used fundamental and technical analysis in a disciplined process to offer specific trade ideas geared towards swing traders.
Alan launched www.420Investor.com in late 2013 as the premier source of information for "Green Rush" investors seeking to capitalize on the proliferation of legalized medical and recreational cannabis. In March 2014, Alan, who is a member of the National Cannabis Industry Association, began to focus solely on the cannabis sector. He launched www.NewCannabisVentures.com in late 2015.
You can follow Alan on Facebook (www.facebook.com/420investor) or on Twitter (https://twitter.com/Invest420). Alan also moderates a large LinkedIn group focused on the cannabis industry, Cannabis Investors & Entrepreneurs (https://www.linkedin.com/groups/6523904)
Stone Fox Capital Advisors is a registered investment advisor founded in 2010. The firm offers portfolio management with a focus on opportunistic stocks providing secular growth trends at an affordable value. An emphasis is placed on fundamental analysis though charts are used for timing entry and exit points.
Mark Holder graduated from the University of Tulsa with a double major in accounting & finance. He's been interested in the stock market since college and began managing investments for friends and family more than 20 years ago. Mark has his Series 65 and is also a CPA.
Invest with Stone Fox Capital's model portfolios on Covestor.com as he makes real time trades. Covestor also allows followers to duplicate the model portfolio in their own brokerage accounts. You can find the portfolio and more details here:
Follow Mark on twitter: @stonefoxcapital
Chris DeMuth Jr. is the founder of Rangeley Capital LLC. Rangeley is an investment firm that focuses on event driven, value-oriented investment opportunities. Rangeley Capital and his value investing forum, Sifting the World (StW), search the world for misplaced bets. Rangeley exploits them for its investors and then Mr. DeMuth writes about them on StW.